Search clinical trials for: Nicotinamide Riboside
Total 1162 results
-
AstraZenecaCompletedSolid TumoursBelgium, France, Netherlands, United Kingdom, Denmark
-
Fox Chase Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Essential Thrombocytosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States
-
AGO Research GmbHGlaxoSmithKlineNot yet recruitingPrimary Peritoneal Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer
-
University of OklahomaTesaro, Inc.RecruitingRecurrent Cervix Cancer | Progressive Cervix CancerUnited States
-
MedSIRPfizerActive, not recruitingMetastatic Prostate CancerSpain
-
University Health Network, TorontoActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Neoadjuvant Treatment | Debulking Surgical ProceduresCanada, United Kingdom, Spain, New Zealand
-
Brown UniversityPfizer; LifespanTerminatedOvarian Cancer | Fallopian Tube Cancer | BRCA1 Mutation | BRCA2 Mutation | High Grade Serous CarcinomaUnited States
-
BeiGeneCompletedAdvanced or Inoperable Gastric CancerUnited States, Hungary, Spain, China, Hong Kong, Japan, Australia, Taiwan, Belgium, Czechia, Singapore, France, Poland, United Kingdom, Romania, Russian Federation, Georgia
-
David Liebner, MDWithdrawnLocally Advanced Leiomyosarcoma | Metastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Stage III Retroperitoneal Sarcoma AJCC v8 | Stage IIIA Retroperitoneal Sarcoma AJCC v8 | Stage IIIB Retroperitoneal Sarcoma AJCC v8 | Stage IV Retroperitoneal Sarcoma AJCC v8United States
-
Massachusetts General HospitalTesaro, Inc.CompletedPancreatic Cancer | Metastatic Pancreatic CancerUnited States
-
zr Pharma & GmbHCompletedNeoplasmsUnited Kingdom, Poland, Slovakia
-
University of Kansas Medical CenterTesaro, Inc.Active, not recruitingPancreatic CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States
-
Sun Yat-sen UniversityNot yet recruitingOvarian Cancer | Primary Peritoneal Cancer | High Grade Serous Adenocarcinoma of Ovary | High Grade Endometrioid Ovarian Cancer | Fallopian-tube CancerChina
-
Sichuan UniversityRecruitingLung Cancer | Extensive-stage Small-cell Lung CancerChina
-
Haider MahdiGlaxoSmithKline; Zenith EpigeneticsRecruitingOvarian Cancer | Recurrent Solid TumorsUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Xiaoxiang ChenRecruitingNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Ovarian Diseases | Adnexal Diseases | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Angiogenesis | Genital Diseases, Female | Antineoplastic Agents | BRCA1... and other conditionsChina
-
University of PennsylvaniaAstraZeneca; Myriad Genetics, Inc.RecruitingHigh Grade Serous CarcinomaUnited States
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Melinda TelliPfizer; BioMarin PharmaceuticalCompletedAdvanced Breast Cancer | HER2/Neu Negative | Triple-Negative Breast CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
Tesaro, Inc.CompletedNeoplasms | Ovarian Neoplasms | Solid Tumor | Hepatic ImpairmentUnited States
-
PfizerMedivation, Inc.Completed
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
The Netherlands Cancer InstituteCompletedBreast Cancer | Ovarian Cancer | Advanced CancerNetherlands
-
Lisette NixonAstraZenecaUnknownNon-small Cell Lung CancerUnited Kingdom
-
University of Michigan Rogel Cancer CenterCompletedBreast CancerUnited States
-
Asan Medical CenterRecruitingBiliary Tract Cancer | DNA Damage Repair DeficiencyKorea, Republic of
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research...RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer | Deleterious PALB2 Gene Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene MutationUnited States
-
National Cancer Institute (NCI)RecruitingEGFR-Mutated Non-Small-Cell Lung Carcinoma | Small Cell/NeuroendocrineUnited States
-
Georgetown UniversityOregon Health and Science University; Tesaro, Inc.TerminatedHomologous Recombination Deficiency | Solid Tumor, AdultUnited States
-
University of Kansas Medical CenterNational Institute on Aging (NIA)Completed
-
University of Texas Southwestern Medical CenterWithdrawn
-
AbbVieCompleted
-
M.D. Anderson Cancer CenterRecruiting
-
Sir Mortimer B. Davis - Jewish General HospitalNot yet recruitingEndometrial Cancer | Uterine Neoplasm | Serous Adenocarcinoma
-
Massachusetts General HospitalPfizer; Prostate Cancer Foundation; Calithera Biosciences, IncNot yet recruiting
-
Stanford UniversityPfizerRecruitingBreast Cancer | Advanced Breast CancerUnited States
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
PfizerMedivation, Inc.CompletedProstate CancerAustralia, United States, Spain, France, Korea, Republic of, Germany, Austria, United Kingdom, Belgium, Hungary, Italy, Brazil, Netherlands, Poland
-
Tempus AIGlaxoSmithKlineActive, not recruitingMelanoma | Head and Neck Cancer | Pancreatic Cancer | Esophageal Cancer | Solid Tumor | Metastatic Cancer | Endometrial Cancer | Urologic Cancer | Breast Tumor | Locally Advanced Solid Tumor | Lung Tumor | Colon Tumor, MalignantUnited States
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax PharmaceuticalsTerminatedFallopian Tube Cancer | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Recurrent Endometrial Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Primary Peritoneal... and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedPregnant Women Undergoing TOP | TOP - Failed Attempted Termination of PregnancyFrance
-
The Netherlands Cancer InstituteCompletedLocally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast CarcinomaNetherlands